Laurion Capital Management LP

Laurion Capital Management LP, established in 2005 by Benjamin A. Smith and Sheehan Maduraperuma, is a hedge fund based in New York City. The firm specializes in global markets, emphasizing relative value and macro strategies. Laurion Capital employs a multi-disciplinary approach, combining quantitative and qualitative analysis to allocate assets across a diverse range of investments in fixed income, commodities, and public equity markets globally. As of March 2024, the firm manages discretionary assets totaling approximately $12.5 billion. The firm's investment portfolio is diversified across various sectors, with significant holdings in consumer discretionary, finance, information technology, utilities and telecommunications, energy, health care, consumer staples, and materials. Notable portfolio companies include Aardvark Therapeutics, Leap Therapeutics, Pyxis Oncology, Pepgen, COMPASS Pathways, MerQube, Axoni, Opensee, Recursion Pharmaceuticals, and Solid Biosciences. Laurion Capital Management LP caters exclusively to pooled investment vehicles, taking advisory fees from a percentage of assets and various performance-based fees.